Injectable Shear-Thinning Hydrogels for Minimally Invasive Delivery to Infarcted Myocardium to Limit Left Ventricular Remodeling

Circulation: Cardiovascular Interventions

Volumn 9, Issue 10, 2016, Pages

  Rodell, Christopher B ^a   Lee, Madonna E ^b   Wang, Hua ^c   Takebayashi, Satoshi ^b   Takayama, Tetsushi ^b   Kawamura, Tomonori ^c   Arkles, Jeffrey S ^b   Dusaj, Neville N ^a   Dorsey, Shauna M ^a   Witschey, Walter R T ^b   Pilla, James J ^b   Gorman, Joseph H ^b   Wenk, Jonathan F ^c,d   Burdick, Jason A ^a   Gorman, Robert C ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

Author keywords

heart failure; hydrogel; myocardial infarction; percutaneous treatment; remodeling

Indexed keywords

ADAMANTANE; BETA CYCLODEXTRIN; HYALURONIC ACID; BIOMATERIAL; CROSS LINKING REAGENT; HYDROGEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC MUSCLE; CONTROLLED STUDY; CROSS LINKING; ECHOCARDIOGRAPHY; EPICARDIUM; FINITE ELEMENT ANALYSIS; FLUOROSCOPY; HEART INFARCTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE VOLUME; HEART VENTRICLE REMODELING; HYDROGEL; INTRACARDIAC ECHOCARDIOGRAPHY; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OVINE MODEL; PRIORITY JOURNAL; YOUNG MODULUS; ANIMAL; BIOLOGICAL MODEL; BIOMECHANICS; BIOPSY; CHEMISTRY; CONVALESCENCE; DIAGNOSTIC IMAGING; DISEASE MODEL; DOMESTIC SHEEP; DRUG EFFECTS; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; INJECTION; MYOCARDIAL INFARCTION; PATHOLOGY; PATHOPHYSIOLOGY; TIME FACTOR;

ANIMALS; BIOCOMPATIBLE MATERIALS; BIOMECHANICAL PHENOMENA; BIOPSY; CROSS-LINKING REAGENTS; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; FINITE ELEMENT ANALYSIS; HYALURONIC ACID; HYDROGELS; INJECTIONS; MAGNETIC RESONANCE IMAGING; MALE; MODELS, CARDIOVASCULAR; MYOCARDIAL INFARCTION; MYOCARDIUM; RECOVERY OF FUNCTION; SHEEP, DOMESTIC; STROKE VOLUME; TIME FACTORS; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84992111157     PISSN: 19417640     EISSN: 19417632     Source Type: Journal    
DOI: 10.1161/CIRCINTERVENTIONS.116.004058     Document Type: Article

References (39)

1. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, de Ferranti S, Després JP, Fullerton HJ, Howard VJ, Huffman MD, Judd SE, Kissela BM, Lackland DT, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Matchar DB, McGuire DK, Mohler ER 3rd, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Willey JZ, Woo D, Yeh RW, Turner MB; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation. 2015;131:e29-e322. doi: 10.1161/CIR.0000000000000152.
2. Peterson ED, Shah BR, Parsons L, Pollack CV Jr, French WJ, Canto JG, Gibson CM, Rogers WJ. Trends in quality of care for patients with acute myocardial infarction in the National Registry of Myocardial Infarction from 1990 to 2006. Am Heart J. 2008;156:1045-1055. doi: 10.1016/j. ahj.2008.07.028.
3. Jessup M, Brozena S. Heart failure. N Engl J Med. 2003;348:2007-2018. doi: 10.1056/NEJMra021498.
4. Holmes JW, Borg TK, Covell JW. Structure and mechanics of healing myocardial infarcts. Annu Rev Biomed Eng. 2005;7:223-253. doi: 10.1146/annurev.bioeng.7.060804.100453.
5. Spinale FG. Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Physiol Rev. 2007;87:1285-1342. doi: 10.1152/physrev.00012.2007.
6. Gupta KB, Ratcliffe MB, Fallert MA, Edmunds LH Jr, Bogen DK. Changes in passive mechanical stiffness of myocardial tissue with aneurysm formation. Circulation. 1994;89:2315-2326.
7. Vanhoutte D, Schellings M, Pinto Y, Heymans S. Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: a temporal and spatial window. Cardiovasc Res. 2006;69:604-613. doi: 10.1016/j. cardiores.2005.10.002.
8. Jackson BM, Gorman JH, Moainie SL, Guy TS, Narula N, Narula J, John-Sutton MG, Edmunds LH Jr, Gorman RC. Extension of borderzone myocardium in postinfarction dilated cardiomyopathy. J Am Coll Cardiol. 2002;40:1160-1167, discussion 1168.
9. Wall ST, Walker JC, Healy KE, Ratcliffe MB, Guccione JM. Theoretical impact of the injection of material into the myocardium: a finite element model simulation. Circulation. 2006;114:2627-2635. doi: 10.1161/CIRCULATIONAHA.106.657270.
10. Gorman RC, Jackson BM, Burdick JA, Gorman JH. Infarct restraint to limit adverse ventricular remodeling. J Cardiovasc Transl Res. 2011;4:73-81. doi: 10.1007/s12265-010-9244-0.
11. Tous E, Purcell B, Ifkovits JL, Burdick JA. Injectable acellular hydrogels for cardiac repair. J Cardiovasc Transl Res. 2011;4:528-542. doi: 10.1007/s12265-011-9291-1.
12. Ifkovits JL, Tous E, Minakawa M, Morita M, Robb JD, Koomalsingh KJ, Gorman JH 3rd, Gorman RC, Burdick JA. Injectable hydrogel properties influence infarct expansion and extent of postinfarction left ventricular remodeling in an ovine model. Proc Natl Acad Sci U S A. 2010;107:11507-11512. doi: 10.1073/pnas.1004097107.
13. Tous E, Ifkovits JL, Koomalsingh KJ, Shuto T, Soeda T, Kondo N, Gorman JH 3rd, Gorman RC, Burdick JA. Influence of injectable hyaluronic acid hydrogel degradation behavior on infarction-induced ventricular remodeling. Biomacromolecules. 2011;12:4127-4135. doi: 10.1021/bm201198x.
14. Leor J, Tuvia S, Guetta V, Manczur F, Castel D, Willenz U, Petneházy O, Landa N, Feinberg MS, Konen E, Goitein O, Tsur-Gang O, Shaul M, Klapper L, Cohen S. Intracoronary injection of in situ forming alginate hydrogel reverses left ventricular remodeling after myocardial infarction in Swine. J Am Coll Cardiol. 2009;54:1014-1023. doi: 10.1016/j.jacc.2009.06.010.
15. Singelyn JM, Sundaramurthy P, Johnson TD, Schup-Magoffin PJ, Hu DP, Faulk DM, Wang J, Mayle KM, Bartels K, Salvatore M, Kinsey AM, Demaria AN, Dib N, Christman KL. Catheter-deliverable hydrogel derived from decellularized ventricular extracellular matrix increases endogenous cardiomyocytes and preserves cardiac function post-myocardial infarction. J Am Coll Cardiol. 2012;59:751-763. doi: 10.1016/j. jacc.2011.10.888.
16. Bastings MM, Koudstaal S, Kieltyka RE, Nakano Y, Pape AC, Feyen DA, van Slochteren FJ, Doevendans PA, Sluijter JP, Meijer EW, Chamuleau SA, Dankers PY. A fast pH-switchable and self-healing supramolecular hydrogel carrier for guided, local catheter injection in the infarcted myocardium. Adv Healthc Mater. 2014;3:70-78. doi: 10.1002/adhm.201300076.
17. Johnson TD, Lin SY, Christman KL. Tailoring material properties of a nanofibrous extracellular matrix derived hydrogel. Nanotechnology. 2011;22:494015. doi: 10.1088/0957-4484/22/49/494015.
18. Rodell CB, Kaminski AL, Burdick JA. Rational design of network properties in guest-host assembled and shear-thinning hyaluronic acid hydrogels. Biomacromolecules. 2013;14:4125-4134. doi: 10.1021/bm401280z.
19. Rodell CB, MacArthur JW, Dorsey SM, Wade RJ, Wang LL, Woo YJ, Burdick JA. Shear-thinning supramolecular hydrogels with secondary autonomous covalent crosslinking to modulate viscoelastic properties in vivo. Adv Funct Mater. 2015;25:636-644. doi: 10.1002/adfm.201403550.
20. Kichula ET, Wang H, Dorsey SM, Szczesny SE, Elliott DM, Burdick JA, Wenk JF. Experimental and computational investigation of altered mechanical properties in myocardium after hydrogel injection. Ann Biomed Eng. 2014;42:1546-1556. doi: 10.1007/s10439-013-0937-9.
21. Gorman JH 3rd, Gorman RC, Plappert T, Jackson BM, Hiramatsu Y, St John-Sutton MG, Edmunds LH Jr. Infarct size and location determine development of mitral regurgitation in the sheep model. J Thorac Cardiovasc Surg. 1998;115:615-622. doi: 10.1016/S0022-5223(98)70326-5.
22. Rodell CB, Mealy JE, Burdick JA. Supramolecular guest-host interactions for the preparation of biomedical materials. Bioconjug Chem. 2015;26:2279-2289. doi: 10.1021/acs.bioconjchem.5b00483.
23. Miyagi Y, Chiu LL, Cimini M, Weisel RD, Radisic M, Li RK. Biodegradable collagen patch with covalently immobilized VEGF for myocardial repair. Biomaterials. 2011;32:1280-1290. doi: 10.1016/j. biomaterials.2010.10.007.
24. Purcell BP, Elser JA, Mu A, Margulies KB, Burdick JA. Synergistic effects of SDF-1 chemokine and hyaluronic acid release from degradable hydrogels on directing bone marrow derived cell homing to the myocardium. Biomaterials. 2012;33:7849-7857. doi: 10.1016/j. biomaterials.2012.07.005.
25. Sherman W, Martens TP, Viles-Gonzalez JF, Siminiak T. Catheter-based delivery of cells to the heart. Nat Clin Pract Cardiovasc Med. 2006;3(suppl 1):S57-S64. doi: 10.1038/ncpcardio0446.
26. Dorsey SM, McGarvey JR, Wang H, Nikou A, Arama L, Koomalsingh KJ, Kondo N, Gorman JH 3rd, Pilla JJ, Gorman RC, Wenk JF, Burdick JA. MRI evaluation of injectable hyaluronic acid-based hydrogel therapy to limit ventricular remodeling after myocardial infarction. Biomaterials. 2015;69:65-75. doi: 10.1016/j.biomaterials.2015.08.011.
27. Fomovsky GM, Holmes JW. Evolution of scar structure, mechanics, and ventricular function after myocardial infarction in the rat. Am J Physiol Heart Circ Physiol. 2010;298:H221-H228. doi: 10.1152/ajpheart.00495.2009.
28. Richardson WJ, Holmes JW. Why is infarct expansion such an elusive therapeutic target? J Cardiovasc Transl Res. 2015;8:421-430. doi: 10.1007/s12265-015-9652-2.
29. White HD, Norris RM, Brown MA, Brandt PW, Whitlock RM, Wild CJ. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation. 1987;76:44-51.
30. Solomon SD, Anavekar N, Skali H, McMurray JJ, Swedberg K, Yusuf S, Granger CB, Michelson EL, Wang D, Pocock S, Pfeffer MA; Candesartan in Heart Failure Reduction in Mortality (CHARM) Investigators. Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation. 2005;112:3738-3744. doi: 10.1161/CIRCULATIONAHA.105.561423.
31. Seif-Naraghi SB, Singelyn JM, Salvatore MA, Osborn KG, Wang JJ, Sampat U, Kwan OL, Strachan GM, Wong J, Schup-Magoffin PJ, Braden RL, Bartels K, DeQuach JA, Preul M, Kinsey AM, DeMaria AN, Dib N, Christman KL. Safety and efficacy of an injectable extracellular matrix hydrogel for treating myocardial infarction. Sci Transl Med. 2013;5:173ra25. doi: 10.1126/scitranslmed.3005503.
32. Venugopal JR, Prabhakaran MP, Mukherjee S, Ravichandran R, Dan K, Ramakrishna S. Biomaterial strategies for alleviation of myocardial infarction. J R Soc Interface. 2012;9:1-19. doi: 10.1098/rsif.2011.0301.
33. Seif-Naraghi SB, Salvatore MA, Schup-Magoffin PJ, Hu DP, Christman KL. Design and characterization of an injectable pericardial matrix gel: a potentially autologous scaffold for cardiac tissue engineering. Tissue Eng Part A. 2010;16:2017-2027. doi: 10.1089/ten.TEA.2009.0768.
34. Burdick JA, Mauck RL, Gorman JH 3rd, Gorman RC. Acellular biomaterials: an evolving alternative to cell-based therapies. Sci Transl Med. 2013;5:176ps4. doi: 10.1126/scitranslmed.3003997.
35. Highley CB, Prestwich GD, Burdick JA. Recent advances in hyaluronic acid hydrogels for biomedical applications. Curr Opin Biotechnol. 2016;40:35-40. doi: 10.1016/j.copbio.2016.02.008.
36. Szejtli J. Introduction and general overview of cyclodextrin chemistry. Chem Rev. 1998;98:1743-1754.
37. Landa N, Miller L, Feinberg MS, Holbova R, Shachar M, Freeman I, Cohen S, Leor J. Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat. Circulation. 2008;117:1388-1396. doi: 10.1161/CIRCULATIONAHA.107.727420.
38. Yoshizumi T, Zhu Y, Jiang H, D'Amore A, Sakaguchi H, Tchao J, Tobita K, Wagner WR. Timing effect of intramyocardial hydrogel injection for positively impacting left ventricular remodeling after myocardial infarction. Biomaterials. 2016;83:182-193. doi: 10.1016/j.biomaterials.2015.12.002.
39. Lee LC, Wall ST, Klepach D, Ge L, Zhang Z, Lee RJ, Hinson A, Gorman JH 3rd, Gorman RC, Guccione JM. Algisyl-LVR with coronary artery bypass grafting reduces left ventricular wall stress and improves function in the failing human heart. Int J Cardiol. 2013;168:2022-2028. doi: 10.1016/j.ijcard.2013.01.003.